Events

Report will be released at 8.00am CET and conference call at 10.00am CET

Julie Waras Brogren, Chief Commercial Officer will present Ascelia Pharma. Live presentation: Erik Penser Bank HealthCare-dag - Sal 1 - 24 februari 2022 - YouTube

Carl Bjartmar will present Ascelia Pharma. Link to the broadcast: https://www.redeye.se/events/825140/redeye-theme-orphan-drugs  

All information and material for the Annual General Meeting 2022 can be found here: General Meeting

Report will be released at 08:00am CET and conference call at 10:00am CET

Magnus Corfitzen will be presenting at Erik Penser Bank Company Day. To watch the interview live: https://youtu.be/FxZQ08Kmjk8

Ascelia Pharma will present at the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) annual conference in Lisbon. More information to come.

Magnus Corfitzen will present Ascelia Pharma at the HC Andersen Oncology Seminar. To register to the live presentation: https://hcandersencapital643.clickmeeting.com/oncology-seminar/register

Report will be released at 08:00am CET and conference call at 10:00am CET

Ascelia Pharma’s CEO Magnus Corfitzen will present at ABGSC Investor Day.  

Report will be released at 08:00am CET and conference call at 10:00am CET

Magnus Corfitzen will give a company presentation. The presentation will be live broadcasted: https://seb.evitbe.com/visitor/default.asp?guestid=16222&wuid=0AD46BEB-287D-4EEF-90C1-41D1FBB5F402&referer=

Magnus Corfitzen will present Ascelia Pharma at ABG Sundal Colliers. The presentation will be livestreamed: https://cr.abgsc.com/

Report will be released at 08:00am CET and conference call at 10:00am CET

Magnus Corfitzen, will present at Life Science Investor in Copenhagen. To register: Life Science Investor

Ascelia Pharma investor update: bringing Orviglance to market - next steps towards launch Live webcast: link will be posted prior to the event.

Julie Waras Brogren, Deputy CEO and CCO will present Orviglance commercial opportunity and progress towards launch. To register: https://www.inderes.dk/videos/ascelia-pharma-orviglance-commercial-opportunity-and-progress-towards-launch

Magnus Corfitzen will present at Redeye Orphan Drug Event with  Q&A panel discussions with  Redeye analysts. Live broadcast: https://www.redeye.se/events/870532/redeye-theme-orphan-drugs-2